Kronos Bio Inc. (NASDAQ: KRON) Stock Information | RedChip

Kronos Bio Inc. (NASDAQ: KRON) Listen to this Section


$1.00
+0.0124 ( +1.26% ) 100.3K

Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription. The company operates in one business segment, the development of biopharmaceutical products.

Market Data


Open


$1.00

Previous close


$0.99

Volume


100.3K

Market cap


$60.26M

Day range


$0.97 - $1.01

52 week range


$0.69 - $1.62

Insider Ownership Transactions

Total Amount Purchased: -523,558.00 | $ -523,558.00

Date Type Amount Purchased Purchaser
2024-06-04 Sale -164260.00 KNOBELMAN DEBORAH
2024-02-23 Sale -7368.00 Olek Elizabeth A
2024-02-23 Sale -12036.00 Lin Charles Y
2024-02-23 Sale -12105.00 Frisbee Allison
2024-02-16 Sale -270339.00 BISCHOFBERGER NORBERT W
2024-01-05 Sale -10676.00 Kosacz Barbara
2024-01-05 Sale -12009.00 DiMartino Jorge
2024-01-05 Sale -7366.00 Dinsmore Christopher
2023-12-13 Sale -10032.00 Dinsmore Christopher
2023-12-13 Sale -17367.00 DiMartino Jorge

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jun 26, 2024
4 Insider transactions 1 Jun 26, 2024
4 Insider transactions 1 Jun 12, 2024
4 Insider transactions 1 Jun 04, 2024
3 Insider transactions 2 Jun 04, 2024
8-k 8K-related 14 May 21, 2024
10-q Quarterly Reports 70 May 09, 2024
8-k 8K-related 15 May 09, 2024
def Proxies and info statements 28 Apr 29, 2024
ars Annual reports 1 Apr 29, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.